May 2013   |   By - La Merie Publishing

Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and...

Nov 2012   |   By - GBI Research

GBI Research, the leading business intelligence provider, has released its latest research “Cell Culture Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities”, which provides in-depth analysis on the processes, drivers and barriers of the cell culture market. The report analyzes the role of biopharmaceutical...

Jul 2012   |   By - GBI Research

GBI Research, the leading business intelligence provider, has released its latest report, Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth that provides key data, information and analysis of the major trends and issues affecting the biosimilar market in developed countries covering the US, the top five European...

Mar 2012   |   By - JustPharmaReports.com

The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in the global biologics market expected to lose some degree of protection by 2019. All major countries now make provision for an abbreviated biosimilar development and regulatory pathway....

Oct 2011   |   By - IMARC

With sales worth US$ 57 Million in 2010, biosimilars are still far from their billion dollar sales potential that most analysts believe they will generate. This market, however, unlike small molecule generics, is expected to be more akin to a marathon than a sprint. IMARC Group, one of the world’s leading research and advisory firms, in its new report...

Apr 2011   |   By - GBI Research

GBI Research, the leading business intelligence provider, has released its latest research, Cancer Supportive Care Products Market to 2016 Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars, which provides insights into the cancer supportive care products market and forecasts until 2016. The report provides an in-depth analysis of the six major cancer...

Dec 2010   |   By - GBI Research

GBI Research, the leading business intelligence provider, has released its latest report, “Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions” that provides key data, information and analysis of the major trends and issues affecting the biotech industry. The report provides a comprehensive insight into the...